Moore Capital Management’s Repligen RGEN Stock Holding History

Moore Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.12M	Buy	+37,549	New	+$4.61M	0.08%	220
2026 Q1	–	Sell	-150,000	Closed	-$24.6M	–	779
2025 Q4	$24.6M	Buy	150,000 +5,000	+3%	+$783K	0.35%	66
2025 Q3	$19.4M	Buy	+145,000	New	+$17.6M	0.27%	86
2024 Q3	–	Sell	-50,000	Closed	-$6.3M	–	543
2024 Q2	$6.3M	Buy	+50,000	New	+$7.84M	0.11%	184
2024 Q1	–	Sell	-35,000	Closed	-$6.29M	–	516
2023 Q4	$6.29M	Buy	35,000 +10,000	+40%	+$1.56M	0.11%	132
2023 Q3	$3.98M	Buy	+25,000	New	+$4.09M	0.07%	191

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Moore Capital Management's RGEN Position: Q2 2026 in Review

Moore Capital Management opened a new position in Repligen (RGEN) in Q2 2026: 37,549 shares worth $5.12M. The stake represents 0.08% of the portfolio and ranks #220 among its holdings. This is a return to the name: Moore Capital Management previously reported a position in RGEN as recently as Q4 2025.

Moore Capital Management first reported a position in RGEN in Q3 2023 and has held it in 6 quarters since. The position peaked at $24.6M in Q4 2025. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Moore Capital Management held 37,549 shares of Repligen worth $5.12M as of Q2 2026.
Repligen was a new Moore Capital Management position in Q2 2026.
Repligen made up 0.08% of Moore Capital Management's portfolio in Q2 2026, its #220 holding.
Moore Capital Management first reported a position in Repligen in Q3 2023 and has held it in 6 quarters since.
Moore Capital Management's Repligen position peaked at $24.6M in Q4 2025.
481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.